231
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluations

Atopiclair

, &
Pages 1223-1230 | Published online: 30 Apr 2009

Bibliography

  • Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereal (Stockh) 1980;92:44-7
  • Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002;46:361-70
  • Novak N, Kruse S, Kraft S, et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002;119:870-5
  • Leung DYM, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60
  • Cookson WO, Ubhi B, Lawrence R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27:372-3
  • Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002;119:166-73
  • Nemoto-Hasebe I, Akiyama M, Nomura T, et al. Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol 2009;129:682-9
  • Niggeman B. The role of the atopy patch test (APT) in diagnosis of food allergy in infants and children with atopic dermatitis. Pediatr Allergy Immunol 2001;12:37-40
  • Gutgesell C, Haise S, Seubert S, et al. Double-blind placebo-controlled house dust-mite control measures in adult patients with atopic dermatitis. Br J Dermatol 2001;145:70-4
  • Holm L, Ohman S, Bengtsson A, et al. Effectiveness of occlusive bedding in the treatment of atopic dermatitis – a placebo-controlled trial of 12 months' duration. Allergy 2001;56:152-8
  • Johansson C, Eshaghi H, Tengvall Linder M, et al. Positive atopy patch test reaction to Malassetia Furfur in atopic dermatitis correlates with a T-helper 2-like peripheral blood mononuclear cells response. J Invest Dermatol 2002;118:1044-51
  • Hide M, Tanaka T, Yamamura Y, et al. IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol 2002;82:335-40
  • Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALLConsensus Report. J Allergy Clin Immunol 2006;118:152-69
  • Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 2004;59:86-92
  • Abramovits W. A clinician's paradigm in the treatment of atopic dermatitis. J Am Acad Dermatol 2005;53:s70-7
  • Data on file Sinclair Pharmaceuticals. Available from: www.atopiclair.com (last accessed April 2009)
  • Maffei Facino R, Carini M, Aldini G, et al. Sparing effect of procyanidines from Vitis Vinifera. A mechanism for their capillary protective action. Arzneimittelforschung 1994;44:592-601
  • Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005;25:151-74
  • Zafirov D, Bredy-Dobreva G, Litchev V, Papasova M. Antiexudative and capillaritonic effects of procyanidines isolated from grape seeds (V. Vinifera), Bulgarian Academy of Science. Acta Physiol Pharmacol Bulg 1990;16:50-3
  • Cristoni A, Di Pierro F, Morazzoni P, et al. Procyanidines from Vitis Vinifera L. and protection against UV-Photo damages. Acta Phytotherapeutica 1998;1:52-6
  • Hopkins SJ. Telmestein. Drugs Today 1993;29:129-31
  • Grassi A, Moretti M, Bisetti A. Un nuovo farmaco muco-attivo con attività anti-proteasica: la Telmesteina. Riv Ital Biol Med 1992;12:67-74
  • Coleman PJ. Evidence for a role of hyaluronan in the spacing of fibrils within collagen bundles in rabbit synovium. Biochim Biophys Acta 2002;1571:173-82
  • Price RD, Berry MG, Navsaria HA. Hyaluronic acid: the scientific and clinical evidence. J Plast Reconstr Aesthet Surg 2007;60:1110-19
  • Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat 2003;14:153-7
  • Teelucksingh S, Mackie ADR, Burt D, et al. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 1990;335:1060-63
  • Kroes BH, Beukelman CJ, Van Den Berg AJJ, et al. Inhibition of human complement by β-glycyrrhetinic acid. Immunology 1997;90:115-20
  • Shin YW, Bae EA, Lee B, et al. In vitro and in vivo antiallergenic effect of Glycyrrhiza Glabra and its components. Planta Med 2007;73:257-61
  • Lee YM, Hirota S, Jippo-Kanemoto T, et al. Inhibition of histamine synthesis by glycyrrhetinic acid in mast cells cocultured with Swiss 3T3 fibroblasts. Int Arch Allergy Immunol 1996;110:272-7
  • Kang OH, Kim JA, Choi YA, et al. Inhibition of interleukin-8 production in the human colonic epithelial cell line HT-29 by 18 beta-glycyrrhetinic acid. Int J Mol Med 2005;15:981-5
  • Homma M, Minami M, Taniguchi C, et al. Inhibitory effects of lignans and flavonoids in saiboku-to, a herbal medicine for bronchial asthma, on the release of leukotrienes from human polymorphonuclear leukocytes. Planta Med 2000;66:88-91
  • Data on file Sinclair Pharmaceuticals, April 2009. Dayan AD. Shea nut oil in topical preparation. Report on potential allergenic risk
  • Abramovits W, Boguniewicz M. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair®) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol 2006;5:236-44
  • Abramovits W, Hebert AA, Boguniewicz M, et al. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair ™) in the management of mild-to-moderate atopic dermatitis in adults. J Dermatolog Treat 2008;19:327-32
  • Patrizi A, Capitanio B, Neri I, et al. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR™) in the management of atopic dermatitis in pediatric patients. Pediat Allergy Immunol 2008;19:619-25
  • Belloni G, Pinelli S, Veraldi S. A randomized, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis. Eur J Dermatol 2005;15:31-6
  • Boguniewicz M, Zeichner JA, Eichenfield LF, et al. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr 2008;152:854-9
  • Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:13-14
  • Sigurjionsdottit HA, Franzson L, Manhem K, et al. Licorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens 2001;15:549-52
  • Berger TG, Duvic M, Van Voorhees AS, et al. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 2006;54:818-23
  • Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000;53:22-9
  • Peserico A, Städtler G, Sebastian M, et al. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008;158:801-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.